809oimmune Correlates and Long Term Follow up of a Phase Ia Study of Mpdl3280a, an Engineered Pd-l1 Antibody, in Patients with Metastatic Renal Cell Carcinoma (mrcc).

@article{Mcdermott2014809oimmuneCA,
  title={809oimmune Correlates and Long Term Follow up of a Phase Ia Study of Mpdl3280a, an Engineered Pd-l1 Antibody, in Patients with Metastatic Renal Cell Carcinoma (mrcc).},
  author={D F Mcdermott and Mario Sznol and Jeffrey A. Sosman and Jean – Charles Soria and Michael S Gordon and Omid A. Hamid and Jean Pierre Delord and Marcella Fass{\`o} and Yan Wang and J Bruey and Gregg D. Fine and Thomas B Powles},
  journal={Annals of oncology : official journal of the European Society for Medical Oncology},
  year={2014},
  volume={25 suppl_4},
  pages={iv280}
}

From This Paper

Topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 17 extracted citations

Clinical use of checkpoint inhibition in kidney cancer.

Clinical advances in hematology & oncology : H&O • 2016

Similar Papers

Loading similar papers…